CEFIC and DSM have said the European Commission's proposals for tackling counterfeit APIs do not go far enough. Responding to the public consultation both parties believe APIs in medicines destined for the EU market must comply with GMP and that there are concerns over some APIs originating from India and China.
In-Pharma Technologist
Thursday 19 June 2008
CEFIC and DSM criticise EU API measures
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment